GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.
Company profile
Ticker
GEHC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GE Healthcare Holding LLC
SEC CIK
Corporate docs
Subsidiaries
Beijing GE Hualun Medical Equipment Company Limited • BK Medical ApS • BK Medical Australia Pty Ltd. • BK Medical Austria GmbH • BK Medical Benelux NV • BK Medical France SAS • BK Medical Holding Company, Inc. • BK Medical Italia S.r.l. • bk medical Medizinische Systeme GmbH • BK Medical Schweiz GmbH ...
IRS number
882515116
GEHC stock data
Analyst ratings and price targets
Latest filings (excl ownership)
S-1
IPO registration
5 Jun 23
SD
Conflict minerals disclosure
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
EFFECT
Notice of effectiveness
24 May 23
424B3
Prospectus supplement
9 May 23
8-K
GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
9 May 23
S-4
Registration of securities issued in business combination transactions
25 Apr 23
424B3
Prospectus supplement
25 Apr 23
10-Q
2023 Q1
Quarterly report
25 Apr 23
8-K
GE HealthCare Reports First Quarter 2023 Financial Results
25 Apr 23
Transcripts
Latest ownership filings
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Institutional ownership, Q1 2023
81.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1004 |
Opened positions | 969 |
Closed positions | 7 |
Increased positions | 21 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 30.20 tn |
Total shares | 368.40 mm |
Total puts | 1.21 mm |
Total calls | 1.84 mm |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
GE General Electric | 90.33 mm | $7.41 tn |
Capital Research Global Investors | 43.44 mm | $3.56 tn |
Vanguard | 36.04 mm | $2.96 tn |
BLK Blackrock | 26.75 mm | $2.19 tn |
T. Rowe Price | 18.32 mm | $1.50 tn |
STT State Street | 17.42 mm | $1.43 tn |
Dodge & Cox | 15.81 mm | $1.30 tn |
FMR | 13.67 mm | $1.12 tn |
Geode Capital Management | 6.78 mm | $554.41 bn |
Capital International Investors | 5.59 mm | $458.65 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jun 23 | Saccaro James | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 5,950 | 0.00 | 61,693 |
1 Jun 23 | Saccaro James | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 11,900 | 0.00 | 55,743 |
1 Jun 23 | Saccaro James | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 43,843 | 0.00 | 43,843 |
1 Jun 23 | Saccaro James | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 79.83 | 54,472 | 4.35 mm | 54,472 |
1 Jun 23 | Saccaro James | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 79.83 | 36,176 | 2.89 mm | 36,176 |
23 May 23 | William J Stromberg | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 1,408 | 0.00 | 4,992 |
23 May 23 | William J Stromberg | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 3,584 | 0.00 | 3,584 |
23 May 23 | Lavizzo-mourey Risa J | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 3,584 | 0.00 | 4,625 |
23 May 23 | Rodney F Hochman | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 1,214 | 0.00 | 4,798 |
23 May 23 | Rodney F Hochman | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 3,584 | 0.00 | 3,584 |
News
General Electric Offloads $2B Stake In GE HealthCare
6 Jun 23
Smucker, Sprinklr And 3 Stocks To Watch Heading Into Tuesday
6 Jun 23
GE HealthCare Announces $30M Order By St. Luke's University Health Network For CT Systems Powered By Artificial Intelligence
25 May 23
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
16 May 23
GE HealthCare Technologies Is Innovating An $84B Market And This Analyst Is Bullish
16 May 23
Press releases
GE HealthCare Technologies Inc. Commences Secondary Offering of 25,000,000 Shares
5 Jun 23
GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI
5 Jun 23
GE HealthCare Technologies Inc. to Join the Nasdaq-100 Index® Beginning June 7, 2023
30 May 23
GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI
30 May 23
GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
24 May 23